Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Tech selling in the US, XJO to open flat
    • Market Update

    Tech selling in the US, XJO to open flat

    The XJO is expected to open flat this morning despite a pullback in the U.S overnight. Yesterday we pulled right back from our highs to finish fairly flat, and coupled with slightly positive U.S futures, this is likely why we are seeing a muted open. Yesterday we tested the key resistance at roughly 7,380 in

    Read More
    Public
  • Rise of flexible work and ‘bleisure’ travel: Flight Centre upgrades earnings guidance
    • News

    Rise of flexible work and ‘bleisure’ travel: Flight Centre upgrades earnings guidance

    You might be reading this news piece from your office desk or from a balcony in sunny Italy. It does not matter. Since the COVID-19 pandemic, we’ve seen a rise in flexible working arrangements, and this has had an impact on business travel both from the company and employee perspectives.  On the one hand, many

    Read More
    Public
  • Reduced consumer confidence chips Michael Hill sales, some stores shutting down
    • News

    Reduced consumer confidence chips Michael Hill sales, some stores shutting down

    It seems fewer people are putting a Michael Hill (ASX: MHJ) ring on it, as the retail company witnesses a decline in its sales and earning. The persisting inflationary environment has left people putting huge life events, like engagements, on the backburner till the wallet can weather this storm. Discretionary spending has declined, and balance

    Read More
    Public
  • June 2023 contracts push Nuix’s total contract value for FY23 over $180 million, legal battles still costing millions
    • News

    June 2023 contracts push Nuix’s total contract value for FY23 over $180 million, legal battles still costing millions

    “Officials from the corporate regulator arrived at the Nuix headquarters in Sydney searching for evidence that the company’s chief executive, Jonathan Rubinsztein, traded shares while possessing confidential information.” Wrong, said tech company Nuix (ASX: NXL), responding to a claim by the Australian Financial Review. For one, the regulators sent an email. Secondly, the investigation took

    Read More
    Public
  • Global markets stall after mixed CPI, earnings
    • Market Update

    Global markets stall after mixed CPI, earnings

    The XJO is expected to open flat this morning following a marginally higher finish for the U.S last night. Their futures have edged into the red which is likely contributing to our muted open. Yesterday we managed to break through 7,280 key resistance convincingly. We had been skirting alongside it for the past couple of

    Read More
    Public
  • Melodiol seeks redemption under new name and leadership, starts with a strong June quarter
    • News

    Melodiol seeks redemption under new name and leadership, starts with a strong June quarter

    Three CEOs within 18 months, a serious listing breach, and an ASX censure. It seems like the stars were not so aligned for cannabis manufacturing company Creso Pharma’s past (formerly ASX: CPH), but with a fresh leadership and a recent name change to Melodiol (ASX: ME1), the Company is back to chasing its American and

    Read More
    Public
  • «
  • ‹
  • 212
  • 213
  • 214
  • 215
  • 216
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.